ArticleFrontiers in chemistry2021

Development of Indole Alkaloid-Type Dual Immune Checkpoint Inhibitors Against CTLA-4 and PD-L1 Based on Diversity-Enhanced Extracts.

Yoshihide Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.